205 related articles for article (PubMed ID: 23140942)
1. UK investments in global infectious disease research 1997-2010: a case study.
Head MG; Fitchett JR; Cooke MK; Wurie FB; Hayward AC; Atun R
Lancet Infect Dis; 2013 Jan; 13(1):55-64. PubMed ID: 23140942
[TBL] [Abstract][Full Text] [Related]
2. Funding infectious disease research: a systematic analysis of UK research investments by funders 1997-2010.
Fitchett JR; Head MG; Cooke MK; Wurie FB; Atun R
PLoS One; 2014; 9(8):e105722. PubMed ID: 25162631
[TBL] [Abstract][Full Text] [Related]
3. Research investments for UK infectious disease research 1997-2013: A systematic analysis of awards to UK institutions alongside national burden of disease.
Head MG; Brown RJ; Clarke SC
J Infect; 2018 Jan; 76(1):11-19. PubMed ID: 29061335
[TBL] [Abstract][Full Text] [Related]
4. Investments in cancer research awarded to UK institutions and the global burden of cancer 2000-2013: a systematic analysis.
Maruthappu M; Head MG; Zhou CD; Gilbert BJ; El-Harasis MA; Raine R; Fitchett JR; Atun R
BMJ Open; 2017 Apr; 7(4):e013936. PubMed ID: 28428185
[TBL] [Abstract][Full Text] [Related]
5. The allocation of USdollar;105 billion in global funding from G20 countries for infectious disease research between 2000 and 2017: a content analysis of investments.
Head MG; Brown RJ; Newell ML; Scott JAG; Batchelor J; Atun R
Lancet Glob Health; 2020 Oct; 8(10):e1295-e1304. PubMed ID: 32971052
[TBL] [Abstract][Full Text] [Related]
6. Research Investments in Global Health: A Systematic Analysis of UK Infectious Disease Research Funding and Global Health Metrics, 1997-2013.
Head MG; Fitchett JR; Nageshwaran V; Kumari N; Hayward A; Atun R
EBioMedicine; 2016 Jan; 3():180-190. PubMed ID: 26870829
[TBL] [Abstract][Full Text] [Related]
7. Comparing research investment to United Kingdom institutions and published outputs for tuberculosis, HIV and malaria: a systematic analysis across 1997-2013.
Head MG; Fitchett JR; Derrick G; Wurie FB; Meldrum J; Kumari N; Beattie B; Counts CJ; Atun R
Health Res Policy Syst; 2015 Nov; 13():63. PubMed ID: 26537547
[TBL] [Abstract][Full Text] [Related]
8. Systematic analysis of funding awarded for mycology research to institutions in the UK, 1997-2010.
Head MG; Fitchett JR; Atun R; May RC
BMJ Open; 2014 Jan; 4(1):e004129. PubMed ID: 24413353
[TBL] [Abstract][Full Text] [Related]
9. Investments in respiratory infectious disease research 1997-2010: a systematic analysis of UK funding.
Head MG; Fitchett JR; Cooke MK; Wurie FB; Hayward AC; Lipman MC; Atun R
BMJ Open; 2014 Mar; 4(3):e004600. PubMed ID: 24670431
[TBL] [Abstract][Full Text] [Related]
10. Mapping pneumonia research: A systematic analysis of UK investments and published outputs 1997-2013.
Head MG; Fitchett JR; Newell ML; Scott JA; Harris JN; Clarke SC; Atun R
EBioMedicine; 2015 Sep; 2(9):1193-9. PubMed ID: 26501117
[TBL] [Abstract][Full Text] [Related]
11. Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010.
Head MG; Fitchett JR; Cooke MK; Wurie FB; Atun R; Hayward AC; Holmes A; Johnson AP; Woodford N
J Antimicrob Chemother; 2014 Feb; 69(2):548-54. PubMed ID: 24038777
[TBL] [Abstract][Full Text] [Related]
12. Funding healthcare-associated infection research: a systematic analysis of UK research investments, 1997-2010.
Head MG; Fitchett JR; Holmes AH; Atun R
J Hosp Infect; 2014 Jun; 87(2):84-91. PubMed ID: 24815767
[TBL] [Abstract][Full Text] [Related]
13. Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments.
McIntosh SA; Alam F; Adams L; Boon IS; Callaghan J; Conti I; Copson E; Carson V; Davidson M; Fitzgerald H; Gautam A; Jones CM; Kargbo S; Lakshmipathy G; Maguire H; McFerran K; Mirandari A; Moore N; Moore R; Murray A; Newman L; Robinson SD; Segaran A; Soong CN; Walker A; Wijayaweera K; Atun R; Cutress RI; Head MG
Lancet Oncol; 2023 Jun; 24(6):636-645. PubMed ID: 37269844
[TBL] [Abstract][Full Text] [Related]
14. Investments in sexually transmitted infection research, 1997-2013: a systematic analysis of funding awarded to UK institutions.
Head MG; Fitchett JR; Cassell JA; Atun R
J Glob Health; 2015 Dec; 5(2):020405. PubMed ID: 26322229
[TBL] [Abstract][Full Text] [Related]
15. UK and European Union public and charitable funding from 2008 to 2013 for bacteriology and antibiotic research in the UK: an observational study.
Bragginton EC; Piddock LJ
Lancet Infect Dis; 2014 Sep; 14(9):857-68. PubMed ID: 25065509
[TBL] [Abstract][Full Text] [Related]
16. Resource allocation to brain research in Europe (RABRE).
Sobocki P; Lekander I; Berwick S; Olesen J; Jönsson B
Eur J Neurosci; 2006 Nov; 24(10):2691-3. PubMed ID: 17156195
[TBL] [Abstract][Full Text] [Related]
17. Systematic analysis of funding awarded for viral hepatitis-related research to institutions in the United Kingdom, 1997-2010.
Head MG; Fitchett JR; Cooke GS; Foster GR; Atun R
J Viral Hepat; 2015 Mar; 22(3):230-7. PubMed ID: 25146854
[TBL] [Abstract][Full Text] [Related]
18. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis.
Kelly R; Zoubiane G; Walsh D; Ward R; Goossens H
Lancet Infect Dis; 2016 Apr; 16(4):431-40. PubMed ID: 26708524
[TBL] [Abstract][Full Text] [Related]
19. Infectious disease research investments: systematic analysis of immunology and vaccine research funding in the UK.
Fitchett JR; Head MG; Atun R
Vaccine; 2013 Dec; 31(50):5930-3. PubMed ID: 24176489
[TBL] [Abstract][Full Text] [Related]
20. UK research expenditure on dementia, heart disease, stroke and cancer: are levels of spending related to disease burden?
Luengo-Fernandez R; Leal J; Gray AM
Eur J Neurol; 2012 Jan; 19(1):149-54. PubMed ID: 21951976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
